Edgewell Personal Care’s analyst price target has been revised downward from $26.00 to approximately $23.86. This adjustment reflects analysts’ updated expectations for slightly lower revenue growth and profit margins, even though there is a modest increase in the anticipated future price-to-earnings ratio.
What's in the News
- Edgewell Personal Care provided fiscal year 2026 earnings guidance, forecasting net sales growth between 0.5% and 3.5%, with GAAP EPS expected to range from $1.10 to $1.50. (Key Developments)
- Organic net sales are projected to vary from a 1% decrease to a 2% increase as part of the company's new guidance. (Key Developments)
- The Board of Directors has authorized a new share buyback plan, effective November 13, 2025. (Key Developments)
- Edgewell announced a share repurchase program to buy back up to $100 million of its shares. (Key Developments)
- The company completed its previous buyback program, repurchasing 9,773,306 shares, which amounted to 19.2% of shares for $356.96 million. (Key Developments)
Valuation Changes
- The consensus analyst price target has been reduced from $26.00 to $23.86, reflecting a lower fair value estimate.
- The discount rate has increased slightly, moving from 10.92% to 10.93%.
- Revenue growth has been revised downward, dropping from 1.86% to 1.32%.
- The net profit margin has decreased from 10.42% to 8.41%.
- The future P/E ratio has risen from 5.85x to 6.87x, indicating higher anticipated earnings multiples.
Have other thoughts on Edgewell Personal Care?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.